Kogan Yakov 4/A
4/A · CLEVELAND BIOLABS INC · Filed Nov 21, 2011
Insider Transaction Report
Form 4/AAmended
Kogan Yakov
DirectorCOO, Secretary
Transactions
- Award
Employee Stock Options (Right to Buy)
2011-11-07+5,000→ 5,000 total(indirect: By Spouse)Exercise: $3.03From: 2011-11-07Exp: 2021-11-06→ Common Stock (5,000 underlying) - Award
Common Stock, par value $0.005 per share
2011-11-17+1,712→ 646,212 total(indirect: By Spouse)
Footnotes (3)
- [F1]On November 7, 2011, the Compensation Committee of Cleveland BioLabs, Inc. (the "Company") approved the grant of 1,638 shares of common stock at a measurement price of $2.78 per share as a quarterly bonus to Leah Brownlee as part of the Company's quarterly bonus program for non-executive employees. The Compensation Committee subsequently decided to move the grant date for all shares granted as part of the referenced bonus program on November 7, 2011 to November 16, 2011. On November 17, 2011, Ms. Brownlee entered into a grant agreement with the Company in respect of such shares. As a result, on November 17, 2011, Ms. Brownlee was issued 1,712 shares of common stock at a measurement price of $2.66, the closing price of the common stock on November 16, 2011. See Note 2 for details on Ms. Brownlee's relationship with the reporting person.
- [F2]Leah Brownlee, who was hired as an employee of the Company effective March 1, 2010, is the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F3]The Compensation Committee approved the grant of these stock options to Leah Brownlee on October 27, 2011, and the grant was finalized and made on November 7, 2011 pursuant to an option agreement that was executed on such date. See Note 2 for details on Ms. Brownlee's relationship with the reporting person.